Literature DB >> 23948159

Update on the classification and treatment of localized scleroderma.

I Bielsa Marsol1.   

Abstract

Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. It comprises a number of subtypes differentiated according to their clinical presentation and the structure of the skin and underlying tissues involved in the fibrotic process. However, classification is difficult because the boundaries between the different types of morphea are blurred and different entities frequently overlap. The main subtypes are plaque morphea, linear scleroderma, generalized morphea, and pansclerotic morphea. With certain exceptions, the disorder does not have serious systemic repercussions, but it can cause considerable morbidity. In the case of lesions affecting the head, neurological and ocular complications may occur. There is no really effective and universal treatment so it is important to make a correct assessment of the extent and severity of the disease before deciding on a treatment approach.
Copyright © 2011 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Keywords:  Atrofodermia de Pasini y Pierini; Atrophoderma of Pasini and Pierini; Deep morphea; Eosinophilic fasciitis; Fascitis eosinofílica; Hemiatrofia facial progresiva; Lichen sclerosus et atrophicus; Liquen escleroso y atrófico; Morfea en coup de sabre; Morfea profunda; Morphea en coup de sabre; Progressive facial hemiatrophy

Mesh:

Substances:

Year:  2013        PMID: 23948159     DOI: 10.1016/j.adengl.2012.10.012

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  15 in total

1.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

Review 2.  Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.

Authors:  Daniel R Mazori; Alisa N Femia; Ruth Ann Vleugels
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

3.  Interventions for morphea.

Authors:  Julia V de Albuquerque; Brenda Ng Andriolo; Monica Ra Vasconcellos; Vinicius T Civile; Anne Lyddiatt; Virginia Fm Trevisani
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

4.  Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports.

Authors:  Justine Vix; Stéphane Mathis; Mathieu Lacoste; Rémy Guillevin; Jean-Philippe Neau
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Persistence of hyaluronic Acid filler for subcutaneous atrophy in a case of circumscribed scleroderma.

Authors:  Shehnaz Z Arsiwala
Journal:  J Cutan Aesthet Surg       Date:  2015 Jan-Mar

Review 6.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

7.  Morphea in Middle Anatolia, Turkey: a 5-year single-center experience.

Authors:  Isil Bulur; Hilal Kaya Erdoğan; Tekden Karapınar; Zeynep Nurhan Saracoglu
Journal:  Postepy Dermatol Alergol       Date:  2017-08-01       Impact factor: 1.837

8.  Linear Morphea Alopecia: New Trichoscopy Findings.

Authors:  Claudia Liliana Montoya; Natalia Calvache
Journal:  Int J Trichology       Date:  2017 Apr-Jun

9.  Pulmonary Disease Secondary to Reflux Mimicking Interstitial Pneumonia in Systemic Sclerosis: Case Report and Literature Review.

Authors:  Ricardo Azêdo de Luca Montes; Nathalia Mazolli Veiga; Pedro Gemal Lanzieri; Luis Otávio Cardoso Mocarzel
Journal:  Case Rep Rheumatol       Date:  2016-01-14

Review 10.  Phototherapy in Scleroderma.

Authors:  John Hassani; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.